Quick Takeaways
- CITADEL ADVISORS LLC filed SCHEDULE 13G for PLIANT THERAPEUTICS, INC. Common stock, par value $0.0001 per share (the "Shares") (PLRX).
- Disclosed ownership: 4.9%.
- Date of event: 14 Jan 2026.
Quoteable Key Fact
"CITADEL ADVISORS LLC disclosed 4.9% ownership in PLIANT THERAPEUTICS, INC. Common stock, par value $0.0001 per share (the "Shares") (PLRX) on 14 Jan 2026."
Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.
| Name | Ownership | Shares Owned | sole voting power | shared voting power | Signature | Title | CIK |
|---|---|---|---|---|---|---|---|
| Citadel Advisors LLC | 3.4% | 2,099,798 | 0 | 2,099,798 | /s/ Seth Levy | Seth Levy, Authorized Signatory | |
| Citadel Advisors Holdings LP | 3.4% | 2,099,798 | 0 | 2,099,798 | /s/ Seth Levy | Seth Levy, Authorized Signatory | |
| Citadel GP LLC | 3.4% | 2,099,798 | 0 | 2,099,798 | /s/ Seth Levy | Seth Levy, Authorized Signatory | |
| Citadel Securities LLC | 1.4% | 863,391 | 0 | 863,391 | /s/ Seth Levy | Seth Levy, Authorized Signatory | |
| Citadel Securities Group LP | 1.5% | 892,117 | 0 | 892,117 | /s/ Seth Levy | Seth Levy, Authorized Signatory | |
| Citadel Securities GP LLC | 1.5% | 892,117 | 0 | 892,117 | /s/ Seth Levy | Seth Levy, Authorized Signatory | |
| Kenneth Griffin | 4.9% | 2,991,915 | 0 | 2,991,915 | /s/ Seth Levy | Seth Levy, attorney-in-fact* |